Nonstandard and off-label therapies for psoriasis

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Although most psoriasis patients respond to standard therapies, many circumstances warrant the use of nonstandard or off-label treatments. For instance, patients with treatment-resistant psoriasis or those who have had multiple adverse effects to other therapies may be good candidates for off-label treatments. Similarly, patients with unusual and hard-to-treat forms of psoriasis such as pustular psoriasis and palmoplantar psoriasis or specific comorbidities may benefit from certain nonstandard therapies. Drugs that may be used as alternatives to standard therapies include mycophenolate mofetil, tacrolimus or pimecrolimus, isotretinoin, colchicine, sulfasalazine, paclitaxel, dapsone, azathioprine, and hydroxyurea. Other unconventional therapies include climatotherapy at the Dead Sea and grenz ray therapy.

Original languageEnglish (US)
Pages (from-to)546-553
Number of pages8
JournalClinics in Dermatology
Volume26
Issue number5
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Psoriasis
Therapeutics
Climatotherapy
Mycophenolic Acid
Isotretinoin
Dapsone
Sulfasalazine
Hydroxyurea
Azathioprine
Colchicine
Tacrolimus
Paclitaxel
Oceans and Seas
Comorbidity
X-Rays
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Dermatology

Cite this

Nonstandard and off-label therapies for psoriasis. / Halverstam, Caroline P.; Lebwohl, Mark.

In: Clinics in Dermatology, Vol. 26, No. 5, 09.2008, p. 546-553.

Research output: Contribution to journalArticle

Halverstam, Caroline P. ; Lebwohl, Mark. / Nonstandard and off-label therapies for psoriasis. In: Clinics in Dermatology. 2008 ; Vol. 26, No. 5. pp. 546-553.
@article{367966e303e54bfd941f54549e4c1d73,
title = "Nonstandard and off-label therapies for psoriasis",
abstract = "Although most psoriasis patients respond to standard therapies, many circumstances warrant the use of nonstandard or off-label treatments. For instance, patients with treatment-resistant psoriasis or those who have had multiple adverse effects to other therapies may be good candidates for off-label treatments. Similarly, patients with unusual and hard-to-treat forms of psoriasis such as pustular psoriasis and palmoplantar psoriasis or specific comorbidities may benefit from certain nonstandard therapies. Drugs that may be used as alternatives to standard therapies include mycophenolate mofetil, tacrolimus or pimecrolimus, isotretinoin, colchicine, sulfasalazine, paclitaxel, dapsone, azathioprine, and hydroxyurea. Other unconventional therapies include climatotherapy at the Dead Sea and grenz ray therapy.",
author = "Halverstam, {Caroline P.} and Mark Lebwohl",
year = "2008",
month = "9",
doi = "10.1016/j.clindermatol.2007.10.023",
language = "English (US)",
volume = "26",
pages = "546--553",
journal = "Clinics in Dermatology",
issn = "0738-081X",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Nonstandard and off-label therapies for psoriasis

AU - Halverstam, Caroline P.

AU - Lebwohl, Mark

PY - 2008/9

Y1 - 2008/9

N2 - Although most psoriasis patients respond to standard therapies, many circumstances warrant the use of nonstandard or off-label treatments. For instance, patients with treatment-resistant psoriasis or those who have had multiple adverse effects to other therapies may be good candidates for off-label treatments. Similarly, patients with unusual and hard-to-treat forms of psoriasis such as pustular psoriasis and palmoplantar psoriasis or specific comorbidities may benefit from certain nonstandard therapies. Drugs that may be used as alternatives to standard therapies include mycophenolate mofetil, tacrolimus or pimecrolimus, isotretinoin, colchicine, sulfasalazine, paclitaxel, dapsone, azathioprine, and hydroxyurea. Other unconventional therapies include climatotherapy at the Dead Sea and grenz ray therapy.

AB - Although most psoriasis patients respond to standard therapies, many circumstances warrant the use of nonstandard or off-label treatments. For instance, patients with treatment-resistant psoriasis or those who have had multiple adverse effects to other therapies may be good candidates for off-label treatments. Similarly, patients with unusual and hard-to-treat forms of psoriasis such as pustular psoriasis and palmoplantar psoriasis or specific comorbidities may benefit from certain nonstandard therapies. Drugs that may be used as alternatives to standard therapies include mycophenolate mofetil, tacrolimus or pimecrolimus, isotretinoin, colchicine, sulfasalazine, paclitaxel, dapsone, azathioprine, and hydroxyurea. Other unconventional therapies include climatotherapy at the Dead Sea and grenz ray therapy.

UR - http://www.scopus.com/inward/record.url?scp=49849090339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49849090339&partnerID=8YFLogxK

U2 - 10.1016/j.clindermatol.2007.10.023

DO - 10.1016/j.clindermatol.2007.10.023

M3 - Article

C2 - 18755374

AN - SCOPUS:49849090339

VL - 26

SP - 546

EP - 553

JO - Clinics in Dermatology

JF - Clinics in Dermatology

SN - 0738-081X

IS - 5

ER -